Retour
Fourchette du Jour
20,15 €
20,98 €
Fourchette 52 Semaines
6,50 €
26,40 €
Volume
1 454 726
Moyenne 50J / 200J
21,61 €
/
16,52 €
Clôture Précédente
21,41 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -5,8 | 0,3 |
| P/B | 3,2 | 2,9 |
| ROE % | -63,3 | 3,7 |
| Net Margin % | -142,9 | 3,8 |
| Rev Growth 5Y % | -10,4 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
28,00 €
+38.3%
Low: 20,00 €
High: 35,00 €
BPA Prévisionnel
-3,81 €
CA Est.
93 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,70 €
0,09 € – 4,24 €
|
970 M | 6 |
| FY2029 |
-0,77 €
-1,93 € – -0,04 €
|
490 M | 6 |
| FY2028 |
-2,19 €
-2,83 € – -1,43 €
|
220 M | 8 |
Points Clés
Revenue declined -10,39% annually over 5 years
Debt/Equity of 0,16 — conservative balance sheet
Negative free cash flow of -484,00M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,13%
Capital efficient — spends only 0,81% of revenue on capex
Croissance
Revenue Growth (5Y)
-10,39%
Revenue (1Y)-4,26%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-63,26%
ROIC-39,66%
Net Margin-142,91%
Op. Margin-156,28%
Sécurité
Debt / Equity
0,16
Current Ratio4,36
Interest Coverage-48,25
Valorisation
P/E Ratio
-5,78
P/B Ratio3,23
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,26% | Revenue Growth (3Y) | 45,30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -10,39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 247,00M | Net Income (TTM) | -353,00M |
| ROE | -63,26% | ROA | -30,99% |
| Gross Margin | 95,95% | Operating Margin | -156,28% |
| Net Margin | -142,91% | Free Cash Flow (TTM) | -484,00M |
| ROIC | -39,66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,16 | Current Ratio | 4,36 |
| Interest Coverage | -48,25 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -5,78 | P/B Ratio | 3,23 |
| P/S Ratio | 8,25 | PEG Ratio | -1,52 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,04B | Enterprise Value | 1,92B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 247,00M | 258,00M | 117,00M | 112,00M | 383,00M |
| Net Income | -353,00M | -283,00M | -307,00M | -267,00M | 53,00M |
| EPS (Diluted) | -3,29 | -3,14 | -4,15 | -3,71 | 0,71 |
| Gross Profit | 237,00M | 258,00M | 117,00M | 112,00M | 383,00M |
| Operating Income | -386,00M | -330,00M | -340,00M | -280,00M | 54,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,14B | 1,15B | 1,10B | 1,35B | 1,59B |
| Total Liabilities | 508,00M | 665,00M | 633,00M | 688,00M | 750,45M |
| Shareholders' Equity | 631,00M | 485,00M | 462,00M | 657,00M | 841,45M |
| Total Debt | 99,00M | 60,00M | 11,00M | 120,00M | 121,99M |
| Cash & Equivalents | 222,00M | 150,00M | 127,00M | 206,00M | 147,91M |
| Current Assets | 1,01B | 1,02B | 831,00M | 1,07B | 1,26B |
| Current Liabilities | 231,00M | 226,00M | 184,00M | 193,00M | 166,08M |